Activities

• 

  Mary Grace N. Tamio   

  on July 22 2023 at 09:09 PM Edited public

  Prevalence of hepatitis C virus among patients with arthralgia: is it logic for screening?
  
  #hepatitisC #arthralgia #journals #articles
  
  More info | ⬇️
  https://social.cn1699.cn/livenewss/news/915319/Prevalence-of-hepatitis-C-virus-among-patients-with-arthralgia-is-it-logic-for-screening

  

  Prevalence of hepatitis C virus among patients with arthralgia: is it logic for screening? | CN1699 Social

  The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
  0 0 0 0 0 0 0

  comment Comment

  thumb_upLike

  share Share
• 

  Mary Grace N. Tamio   

  on May 21 2021 at 07:42 PM Edited public

  When Medicare chips in on hepatitis C treatment for Medicaid patients, everyone wins
  
  #medicarechips #hepatitisC #hepatitisCtreatment
  
  For more information | ⬇️
  https://cn1699.com/news/when-medicare-chips-hepatitis-c-treatment-medicaid-patients-everyone-wins

  

  When Medicare chips in on hepatitis C treatment for Medicaid patients, everyone wins | CN1699

  New USC study finds that a Medicaid-Medicare partnership could cover the lifesaving medications—and still save $1 to $1.1 billion over 25 years....
  0 0 0 0 0 0 0

  comment Comment

  thumb_upLike

  share Share
• 

  Mary Grace N. Tamio   

  on April 28 2021 at 12:18 PM Edited public

  Hepatitis C drugs boost remdesivir's antiviral activity against COVID-19
  Primary tabs
  
  #hepatitisC #remdesivir #covid19
  
  For more information | ⬇️
  https://cn1699.com/news/hepatitis-c-drugs-boost-remdesivirs-antiviral-activity-against-covid-19

  

  Hepatitis C drugs boost remdesivir's antiviral activity against COVID-19 | CN1699

  Remdesivir is currently the only antiviral drug approved in the U.S. for treating COVID-19 patients. In a paper published this week in Cell...
  0 0 0 0 0 0 0

  comment Comment

  thumb_upLike

  share Share